GSK and Genentech settle Cabilly patent lawsuit 28 Mar 2012Scott Beeser GlaxoSmithKline and Genentech have settled a U.S. lawsuit related to Genentech’s Cabilly II (US 6,331,415) and Cabilly III (US 7,923,221) patents. In... Read More
